Treatment search

Depression Treatment Market Expected to Grow USD 16.06 Billion by 2027 | Top Players Pfizer, Allergan Plc, AstraZeneca

Emerging research logo

Depression treatment market size – USD 12.06 billion in 2019, market growth – CAGR of 3.9%

VANCOUER, BC, CANADA, April 5, 2022 / — The global brachytherapy market is expected to reach USD 548.8 million by 2027, according to current analysis by Emergen Research. The depression treatment market is witnessing increased demand attributed to its increasing application in cancer treatment. Cancer has a significant impact on global society. According to statistics published by the National Cancer Institute, approximately 1,806,590 new cases of cancer will be diagnosed in the United States in 2020, resulting in the death of 606,520 people. In 2020, prostate, colorectal and lung cancers will be responsible for an expected 43.0% of cases diagnosed in men. On the other hand, breast, colorectal and lung cancers are the most common causes of cancer in women and will be responsible for approximately 50.0% of diagnosed cases.

The global depression treatment market is highly fragmented with major, medium and new entrants accounting for significant market share. Some key factors driving the growth of the market are increase in initiatives aimed at raising awareness about the advantages and benefits of advanced prostheses, government and NGO funded programs and activities related to these solutions and their deployment, as well as the increased investment in the health sector around the world, among others.

The main participants are Pfizer, Inc., AstraZeneca, Plc, GlaxoSmithKline Plc, Eily, Lilly, and Company, Allergan Plc, Takeda Pharmaceutical Company Limited, Intellipharmaceutics International, Inc., Otsuka Holdings Co. Ltd., H.Lundbeck A/S , and Apotex, Inc., among others.

Request Sample Copy of Report @

The global depression treatment market is expected to be worth USD 16.06 billion by 2027, according to current analysis by Emergen Research. The increasing incidence of mental health and depression is creating a demand for the market. Growing geriatric population and rise in diseases such as anxiety disorders, phobia, and dementia will impact the growth of the market. Low drug cost coupled with affordable therapies is expected to propel the growth of the depression treatment market.

A major market driving factor is an increase in generic drug manufacturers. The lower cost of antidepressants and other medications has encouraged people to opt for the treatment. Moreover, increased awareness of the treatment also encourages people to opt for the procedure. The growing awareness has led people to gain more knowledge about the disease and get rid of the old stigma attached to it. People understand the need for treatment and are opting for a healthier lifestyle.

Research methodology :

Data triangulation and market breakdown

Research hypotheses Research data, including primary and secondary data

Primary data includes primary breakdown and key industry insights

Secondary data includes key data from secondary sources

Some key highlights of the report;

Antipsychotic treatment has been used to treat depressive disorders. The drug was used in conjunction with antidepressants and became the treatment choice for depressed patients who presented with psychotic symptoms. Antipsychotic treatment was done to treat symptoms such as delusions, hallucinations, or marina symptoms. It is also used to treat bipolar depression.

Major depressive disorder (MDD), also known as clinical depression, is a condition that affects behavior and mood as well as physical functions, such as appetite and sleep. It’s one of the most common mental health conditions, and studies suggest nearly 7% of adults in the United States suffered from the condition in 2017.

Hospitals held the biggest share in 2019 as most cases of depression were recognized when they were checked into a hospital for treatment. Few people are aware of their symptoms and go to hospitals for treatment when things get a little extreme. There are also special services and doctors for patients who suffer from depression during their treatment.

To Know More About Depression Treatment Market Report Visit @

Market segment;

The global Depression Treatment Market has been categorized based on product type, application, and region. Our expert analysts undertake an in-depth assessment of all the segments included in the report and analyze them based on their market share, revenue, market growth rate, and other vital factors. The segmentation allows interested parties to determine sectors of the global Depression Treatment Market with strong growth prospects and to understand the growth strategies adopted by leading segments during the forecast period.

For the purposes of this report, Emergen Research has segmented the global depression treatment market on the basis of drug type, application, end-user, distribution channel, and region:

Drug Type Outlook (Revenue, USD Billion; 2017-2027)
Selective serotonin reuptake inhibitors (SSRIs)
Selective norepinephrine reuptake inhibitors (SNRIs)
Serotonin Modulators
Tricyclic and tetracyclic antidepressants
Atypical antidepressants

Application Outlook (Revenue, USD Billion; 2017-2027)
Major Depressive Disorder (MDD)
Bipolar disorder
Postpartum depression

Premenstrual dysphoric disorder (PMDD)
Seasonal Affective Disorder (SAD)

We can customize our reports for our clients, for example, we can add or remove manufacturers, applications or product types, whatever you need in the report. Request it by contacting us @

End User Outlook (Revenue, USD Billion; 2017-2027)
Mental health centers

Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
In line

The regional bifurcation of the depression treatment market includes:

North America (USA, Canada)
Europe (UK, Italy, Germany, France, Rest of EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, Rest of MEA)

We provide detailed product mapping and investigation of various market scenarios. Our expert analysts provide in-depth analysis and market presence breakdown of key market leaders. We strive to stay up to date with recent developments and follow the latest company news related to industry players operating in the global depression treatment market.

Answers to key questions in the report:

What will be the size of the depression treatment market in terms of value and volume over the next five years?

Which segment currently dominates the market?

In which region will the market see its strongest growth?

Which players will take the lead in the depression treatment market?

What are the key drivers and restraints for the growth of the Depression Treatment market?

Explore More Emergen @ Research Reports

Bioelectric Medicine Market @

Molecular Imaging Market @

Bionics Market @

Vaccine Market @

Laparoscopy and Endoscopy Devices Market @

Forensic Technology Market @

Metastatic Cancer Treatment Market @

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting firm with an extensive knowledge base on cutting-edge and potentially market-disrupting technologies that are expected to become more prevalent over the next decade.

Eric Lee
Emerging research
+91 90210 91709
write to us here
Visit us on social media: